Evidence map›Paper›PMID 31045315›Full record

ArticleAnnals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc2019

Continuous 4-week ECG monitoring with adhesive electrodes reveals AF in patients with recent embolic stroke of undetermined source.

Tuomas J Lumikari, Jukka Putaala, Anne Kerola, Gerli Sibolt, Jani Pirinen, Sami Pakarinen, Mika Lehto, Tuomo Nieminen

2 registry-linked trialsOpen access · bronzeAbstract read
In one paragraph

Article in Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06542770 narecruitingnot on this mapstarted 2021, after this paper: background citation

Subtle Ultrasound Atrial Anomalies Predicts the Early Diagnosis of Silent Atrial Fibrillation Detected by Implantable Cardiac Monitor in Patients With Cryptogenic Stroke. A Randomized Trial

TypeinterventionalSponsorParc de Salut MarRan2021 to 2024Enrolled100ConditionsParoxysmal Atrial Fibrillation, Cardiac Rhythm Disorder, Left Atrial Dilatation, Cryptogenic StrokeArmsEarly implant of cardiac monitor
NCT07295769 narecruitingnot on this mapstarted 2026, after this paper: background citation

Atrial Fibrillation Detection Using MEMO Patch in Patients With Stroke of Unknown Cause: A Single-Center, Prospective, Exploratory Trial to Validate the Efficacy and Safety of Noninvasive Long-Term Electrocardiographic Monitoring

TypeinterventionalSponsorAsan Medical CenterRan2026 to 2029Enrolled100ConditionsEmbolic Stroke of Undetermined SourceArmsMEMO Patch M and MEMO Patch2
3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. New Technologies for Detection and Management of Atrial Fibrillation.Journal of the Saudi Heart Association · 2021
    Review
  9. Prolonged ECG with a novel recorder utilizing electrode belt and mobile device in patients with recent embolic stroke of undetermined source: A pilot study.Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc · 2020
    Article
  10. Observational
  11. Continuous 4-week ECG monitoring with adhesive electrodes reveals AF in patients with recent embolic stroke of undetermined source.Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc · 2019
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Tuomas J LumikariDepartment of Neurology, Helsinki University Hospital, Helsinki, Finland.ORCID 0000-0002-5592-5938
Jukka PutaalaDepartment of Neurology, Helsinki University Hospital, Helsinki, Finland.ORCID 0000-0002-6630-6104
Anne KerolaDepartment of Internal medicine, Päijät-Häme Central Hospital, Lahti, Finland.ORCID 0000-0003-2257-3291
Gerli SiboltDepartment of Neurology, Helsinki University Hospital, Helsinki, Finland.ORCID 0000-0003-4815-073X
Jani PirinenDepartment of Clinical Physiology and Nuclear Medicine, HUS Medical Imaging Center, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.ORCID 0000-0002-4030-9358
Sami PakarinenDepartment of Cardiology, Heart and Lung Center, Helsinki University Hospital, Finland.ORCID 0000-0002-5904-5954
Mika LehtoDepartment of Cardiology, Heart and Lung Center, Helsinki University Hospital, Finland.ORCID 0000-0002-8691-5142
Tuomo NieminenDepartment of Internal medicine, Päijät-Häme Central Hospital, Lahti, Finland.ORCID 0000-0003-1755-1688
Helsinki University Hospital · FIPäijät-Hämeen Keskussairaala · FIUniversity of Helsinki · FI

Funding

Helsinki and Uusimaa Hospital District (TYH2016127 and TYH2017237)
6 · The paper itself

Abstract

backgroundAtrial fibrillation (AF) frequently escapes routine stroke workup due to its unpredictable and often asymptomatic nature, leaving a significant portion of patients at high risk of recurrent stroke. Recent trials emphasized continuous electrocardiogram (ECG) monitoring in the detection of occult AF. We screened AF in patients meeting the embolic stroke of unknown source (ESUS) criteria using an external miniaturized recorder with an adhesive electrode.

methodsPatients aged ≥50 with recent ESUS were prospectively screened and assigned to wear a 1-lead ECG device capable to record continuous ECG for up to 4 weeks. Electrodes were replaced every 3-4 days. Primary outcome was proportion of patients completing at least 80% of monitoring. Secondary outcome measures included incidence of AF and initiation of oral anticoagulation therapy after AF detection.

resultsFifty-seven patients were monitored (mean age 64.5 ± 8.2 years, median delay from stroke to the start of monitoring 8 days, IQR 4-44). Of these, 51 patients (89.5%) completed at least 80% of the desired monitoring period. We detected AF ≥30 s in seven patients (12.3%), all of whom initiated anticoagulation therapy. Atrial fibrillation was revealed in six patients (85.7%) within the first week of monitoring. Compared to patients without AF, patients with AF were older (70.6 ± 5.1 vs. 63.6 ± 8.3 years, p < 0.011) and more obese (body mass index 30.0 ± 3.4 vs. 26.6 ± 4.6, p < 0.039).

conclusionsProlonged ECG monitoring with an external device using adhesive electrodes is feasible in ESUS patients, since nine out of ten patients used the device appropriately and AF was detected in one out of eight patients.

Indexed as

Electrocardiography, AmbulatoryAgedAnticoagulantsAtrial FibrillationElectrodesFemaleHumansMaleMiddle AgedProspective StudiesRisk FactorsStrokeTime FactorsAnticoagulantsatrial fibrillationelectrocardiogramembolic stroke of undetermined sourcestroke

Identifiers

PMID31045315
PMCPMC6850068
OpenAlexW2942523221

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.